Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3Breast 3Plasma cell 1Other 1Lymphoid 1Genitourinary 1

Conditions

Vesico-Ureteral Reflux 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Signs and Symptoms 1Prostatic Neoplasms 1Postoperative Complications 1Pathologic Processes 1Pain, Postoperative 1Pain 1Neurologic Manifestations 1Nephrolithiasis 1Kidney Neoplasms 1Inflammation 1Carcinoma, Renal Cell 1Agnosia 1

Interventions

Ropivacaine 2Bupivacaine 2salicylhydroxamic acid 1Tea 1Surgical Procedures, Operative 1Saline Solution 1Parapsychology 1Morphine 1Methadone 1Magnesium Sulfate 1Injections, Epidural 1Dexmedetomidine 1Cystoscopy 1Acetazolamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pain, Postoperative × Morphine × Genitourinary × Clear all
NCT04475029 2023-09-13

METAMORF

University of Aarhus

Phase NA Completed
114 enrolled
Genitourinary

Urinary Bladder Neoplasms, Neurologic Manifestations, Pain, Pain, Postoperative, Pathologic Processes, Postoperative Complications, Signs and Symptoms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡